Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Almirall ( (ES:ALM) ) has issued an announcement.
Almirall’s Board of Directors has approved updated internal regulations that codify the principles guiding the board’s actions, its organizational structure, and the conduct expected from directors and senior managers. The rules are designed to complement existing law and the company’s bylaws, ensuring alignment with corporate governance recommendations for listed companies in Spain and comparable markets.
The document details procedures for interpreting and amending the regulations, including who may propose changes, the requirement for explanatory reports, and the need for an absolute board majority to validate amendments. By formalizing these governance processes and mandating familiarity and compliance among directors and senior managers, Almirall reinforces its governance framework, which may enhance oversight, transparency, and stakeholder confidence.
The most recent analyst rating on (ES:ALM) stock is a Buy with a EUR12.50 price target. To see the full list of analyst forecasts on Almirall stock, see the ES:ALM Stock Forecast page.
More about Almirall
Almirall, S.A. is a Spanish listed company in the pharmaceutical industry, focused on researching, developing, and commercializing medicines. The company operates under Spain’s corporate governance framework for public companies, with a Board of Directors overseeing strategic decisions and compliance with capital markets regulation.
Average Trading Volume: 164,585
Technical Sentiment Signal: Buy
Current Market Cap: €2.46B
Find detailed analytics on ALM stock on TipRanks’ Stock Analysis page.